October 21, 2014 /

Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne (October 2014)

Efficacy of Catena®/Raxone® (Idebenone) on Respiratory Outcome in Duchenne: Results of the phase 3 double-blind, randomized, placebo-controlled DELOS trial. Santhera Pharmaceuticals presented data of the Phase III DELOS trial during a webinar hosted by Parent Project Muscular Dystrophy on Wednesday, October 15th.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo